Second line chemotherapy

DRUG2 trials

Sponsors

Hoffmann-La Roche, Boehringer Ingelheim

Conditions

Breast CancerSquamous Non-small Cell Lung Cancer

Phase 2

A Study of Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

CompletedNCT00444587

Hoffmann-La RocheBreast Cancer

Start: 2007-03-31End: 2011-08-31Updated: 2016-06-21

Unknown Phase

A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung

CompletedNCT04552535

Boehringer IngelheimSquamous Non-small Cell Lung Cancer

Start: 2020-05-08End: 2020-05-18Updated: 2022-01-11

Related Papers

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial.

2021-06-1812 citations